• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Boston Scientific ordered to pay $26.7 million over mesh devices

Boston Scientific ordered to pay $26.7 million over mesh devices

November 14, 2014 By MassDevice Contributors Network

Boston Scientific ordered to pay $26.7 million over mesh devices

(Reuters) — Boston Scientific (NYSE:BSX) was ordered late yesterday to pay 4 women a total of $26.7 million after it was found liable for selling faulty transvaginal mesh devices, following 1 of the 1st federal trials resulting from thousands of lawsuits over the devices.

After deliberating for a few hours, a Miami federal court jury found Boston Scientific liable following an 8-day trial. Plaintiffs said they suffered injuries such as pain, bleeding and infection as a result of the company’s Pinnacle device, used to treat pelvic organ prolapse and stress urinary incontinence.

The company was ordered to pay the women $26.7 million in compensatory damages, between $6.5 million and $6.7 million each. It will not face additional punitive damages.

Boston Scientific is facing 14,000 federal lawsuits over its mesh devices. It is 1 of 7 companies – including Johnson & Johnson‘s (NYSE:JNJ) Ethicon and C.R. Bard (NYSE:BCR) – that have been hit with lawsuits over the products. Endo Health Solutions (NSDQ:ENDP) said in September it had set aside $1.6 billion to settle "substantially all" the cases against it and its American Medical Systems unit.

During the Miami trial, plaintiffs’ lawyers accused Boston Scientific of failing to perform critical safety studies in its rush to bring the device to market. The company denied it had done anything wrong and said each woman and her doctor had been aware of the risks.

One plaintiff, Amal Eghnayem, said the verdict was fair. Jim Perdue, a lawyer for the plaintiffs, said, "this company needs to understand that jurors will understand what (it) did, and will not hesitate to award the damages necessary."

A representative for Boston Scientific, Kelly Leadem, said the company disagreed with the verdict and believed it had strong grounds to challenge in post-trial motions and on appeal.

Boston Scientific previously faced 3 trials in state court over the mesh, resulting in 2 wins for the company and 1 $73 million loss, later reduced to $34 million.

Boston Scientific is currently in another federal trial in West Virginia involving claims from 4 women implanted with the company’s Obtryx device for stress urinary incontinence.

The Miami and West Virginia cases are both "bellwether," or test, trials, that will help both sides assess the claims’ value.

Filed Under: Legal News, News Well Tagged With: Boston Scientific, Pelvic Mesh Lawsuits

More recent news

  • Neuralink files to raise $649M in new equity offering
  • BofA: surgical robot remanufacturing not a major setback for Intuitive
  • InspireMD wins CE Mark approval for CGuard Prime
  • Philips reports first cases for VeriSight Pro 3D ICE catheter in Europe
  • Ceryx Medical raises $15M to support bioelectronic pacemaker

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy